Zoja, Carla <br/><br/>
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.  [electronic resource] 

 -  Arthritis and rheumatism  May 2007 
 - 1629-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.22593  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--therapeutic use<br/>Autoimmunity--drug effects<br/>B-Lymphocytes--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Female<br/>Glomerulonephritis--drug therapy<br/>Longevity--drug effects<br/>Lupus Erythematosus, Systemic--complications<br/>Methylprednisolone--therapeutic use<br/>Mice<br/>Mice, Inbred NZB<br/>Mice, Inbred Strains<br/>Protein Kinase Inhibitors--pharmacology<br/>Proteinuria--drug therapy<br/>Purines--pharmacology<br/>Roscovitine<br/>T-Lymphocytes--drug effects